Your browser doesn't support javascript.
loading
Dinucleotide Degradation by REXO2 Maintains Promoter Specificity in Mammalian Mitochondria.
Nicholls, Thomas J; Spåhr, Henrik; Jiang, Shan; Siira, Stefan J; Koolmeister, Camilla; Sharma, Sushma; Kauppila, Johanna H K; Jiang, Min; Kaever, Volkhard; Rackham, Oliver; Chabes, Andrei; Falkenberg, Maria; Filipovska, Aleksandra; Larsson, Nils-Göran; Gustafsson, Claes M.
Afiliação
  • Nicholls TJ; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, PO Box 440, Gothenburg 405 30, Sweden.
  • Spåhr H; Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden; Max Planck Institute for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Instit
  • Jiang S; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden; Max Planck Institute for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm 17177, Sweden.
  • Siira SJ; Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia; Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
  • Koolmeister C; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden; Max Planck Institute for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm 17177, Sweden.
  • Sharma S; Department of Medical Biochemistry and Biophysics, Umeå University, Umeå 901 87, Sweden.
  • Kauppila JHK; Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.
  • Jiang M; Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.
  • Kaever V; Research Core Unit Metabolomics, Hannover Medical School, 30625 Hannover, Germany.
  • Rackham O; Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia; School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, WA 6102, Australia; Curtin Health Innovation Research Institute, Curtin University, Bentley, WA 6102, Australia.
  • Chabes A; Department of Medical Biochemistry and Biophysics, Umeå University, Umeå 901 87, Sweden.
  • Falkenberg M; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, PO Box 440, Gothenburg 405 30, Sweden.
  • Filipovska A; Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia; School of Molecular Sciences, The University of Western Australia, Nedlands, WA, Australia.
  • Larsson NG; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden; Max Planck Institute for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: nils-goran.larsson@ki.se.
  • Gustafsson CM; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, PO Box 440, Gothenburg 405 30, Sweden. Electronic address: claes.gustafsson@medkem.gu.se.
Mol Cell ; 76(5): 784-796.e6, 2019 12 05.
Article em En | MEDLINE | ID: mdl-31588022
ABSTRACT
Oligoribonucleases are conserved enzymes that degrade short RNA molecules of up to 5 nt in length and are assumed to constitute the final stage of RNA turnover. Here we demonstrate that REXO2 is a specialized dinucleotide-degrading enzyme that shows no preference between RNA and DNA dinucleotide substrates. A heart- and skeletal-muscle-specific knockout mouse displays elevated dinucleotide levels and alterations in gene expression patterns indicative of aberrant dinucleotide-primed transcription initiation. We find that dinucleotides act as potent stimulators of mitochondrial transcription initiation in vitro. Our data demonstrate that increased levels of dinucleotides can be used to initiate transcription, leading to an increase in transcription levels from both mitochondrial promoters and other, nonspecific sequence elements in mitochondrial DNA. Efficient RNA turnover by REXO2 is thus required to maintain promoter specificity and proper regulation of transcription in mammalian mitochondria.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / Biomarcadores Tumorais / Regiões Promotoras Genéticas / Estabilidade de RNA / Proteínas 14-3-3 / Exorribonucleases / RNA Mitocondrial / Mitocôndrias Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / Biomarcadores Tumorais / Regiões Promotoras Genéticas / Estabilidade de RNA / Proteínas 14-3-3 / Exorribonucleases / RNA Mitocondrial / Mitocôndrias Idioma: En Ano de publicação: 2019 Tipo de documento: Article